FDA Investigator Demitria J Xiradakis

Demitria J Xiradakis has inspections in 9 countries as of 23 Oct 2023. Demitria J Xiradakis has collaborated with a combinined 5477 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
139
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Italy, Spain, France, India, Jordan, Switzerland, Austria
Co-Investigator(s):
Alice S Tsao, Alicia M Mozzachio, Althea A Williams, Amatul H Marium, Amber D Brodas, Angela Jourdain, Anissa M Vargas, Anita Narula, PhD, Ann M Stewart, Anna M Alexander, Anna M Brannen, Anthony C Warchut, Antonina Aydanian, Armia A Beshay, Arsen Karapetyan, Aziz A Mamur, Barbara J Maulfair, Barbara J Rincon, Barbara M Frazier, Benton M Ketron, Betty M Ng Lee, Bijoy Panicker, Brandy N Lepage, Brooke K Higgins, Byungja E Marciante, Carla A Norris, Carla J Lundi, Caryn M Mcnab, Charanjeet Jassal, Charanjeet Jassal() (Cj), Charisse K Green, Charles J Chacko, Charles Jewell, Cheryl A Clausen, Christopher D Leach, Christopher R Czajka, Christopher S Fields, Christopher T Peters, Concepcion Cruz, Jr, Courtney N Long, Cynthia J Lee, MS, D Jeany Argiropoulos, D Jenny Argiropoulos, D Jennyxirakis Xiradakis, Darren S Brown, David H Smith, David R Delucia, Deborah B Nixon, Debra I Love, Demetria J Arpropractor, Demitria J Argiiropoulos, Demitria J Argiropolous, Demitria J Argiropoulos, Denise M Digiulio, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Diane L Raccasi, Don H Bark, PhD, Donald G Gordon, Dongping Dai, PhD, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Ellen P Madigan, Emily J Orban, Emily J Schramm, Eric M Mueller, PharmD, Erik W Koester, Erika V Butler, Erin C Hill, Evan Tong, Evelyn Taha, Farhana Khan, Fatima Bassa, Felix Maldonado, Frank Verni, Frederick Razzaghi, Freyja V Lynn, Gam S Zamil, Gary J Lehr, Gary T Greco, Geoffrey K Kilili, Gifford Whitehurst, Jr, Gregson A Joseph, Gregson Joseph, Guerlain Ulysse, Helen B Ricalde, Iram R Hassan, PhD, Irina Gaberman, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, James Norman, Jane Chen, Janet A Rajan, Javier E Santos, Jawaid Hamid, Jeffery A Hangartner, Jeffrey A Sommers, Jennifer C Adams, Jennifer L Bridgewater, Jenny Argiropoulos, Jogy George, John A Podsadowski, John P Mistler, Johnna L Bleem, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose O Hernandez, Jose Ohernandez Guzman, Joseph J Vannelli, Joseph Milcetic, Joy P Matthias, Juan Rjimenez Garcia, Juanita P Versace, Juklian M Badalucco, Juliana M Badalucco, Julie D Bringger, Justine Tomasso, Karen L Kosar, Karishma G Gopaul, Katherine Szestypalow, Kathryn A Nagy, Kelli F Dobilas, Kellia N Hicks, Kellie Leveille, Kenneth H Williams, Kerun Hardeo, Kevin A Gonzalez, Kevin J Flessa, Kham Phommachanh, Kim Lthomas Cruse, Kim Thomasc Rice, Kimberley A Ricketts, Kristina L Conroy, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Lata C Mathew, PhD, Lawrence J Stringer, Lawrence W Farina, LCDR Chad N Thompson, Leena Thomas, Libia M Lugo, Linda F Murphy, Lori P Peters, Lourdes Valentin Aponte, Luis M Burgos Medero, Lydia Irosas Marty, Manhar R Patel, Marcia D Fields, Margaret E Sarles, Margaret M Sands, Maria Joselopez Barragan, PhD, Marie Elena C Puleo, Marie F Morin, Marjorie A Shapiro, PhD, Mark R Mcclain, Marsha W Major, Martha T Olone, Mary Davis Lopez, Mary F Finn, Mary M Finn, Mate Tolnay, Matthew A Spalazo, Matthew A Sparato, Matthew A Spataro, Meisha R Sampson, Meisha Waters, Melissa J Garcia, Meredith P Soehl, Investigator, Michael A Charles, Michael G Mayfield, Michael L Casner, Michael Levin, Michael Levine, Michael P Sheehan, Michael R Dominick, Michael Serrano, Michele Perry Williams, Miguel A Martinez, Mihaly S Ligmond, Milan S Blake, Mindy M Chou, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Mra Munizn, Muralidhara B Gavini, PhD, Nancy A Saxenian Emmons, Nancy T Waites, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicole E Knowlton, Niketa Patel, Omotunde O Osunsanmi, Paraluman S Leonin, Parul M Patel, Paul A Bonneau, Paul E Stein, Paul L Bellamy, Paul Mouris, Paula A Trost, Perry T Nichols, Peter Abel, Peter Caparelli, Peter M Trunk, Peter R Caparelli, Philip F Istafanos, DMV, MS, Prabhu P Raju, Rachael A Moliver, Rachael O Oyewole, Rajiv R Srivastava, Ramon A Hernandez, Ramon E Martinez, Raymond T Oji, Reba A Gates, Rebecca Rodriguez, Richard K Glabach, Richard W Thornton, Rober C Horan, PhD, Robert C Howard, Robert C Steyert, Robert D Tollefsen, Robert G Ruff, Robert J Doyle, Robert J Martin, Robert Jennings, Robert W Jennings, Rochelle K Kimmel, Ronald Ifraimov, Roseline N Boateng, Ruben C Quintana, S Thomas, Samina S Khan, Samuel T Walker, Sandra A Hughes, Sandra D Thompson, Sanket N Patel, Sarah A Meehan, Sarah B Tanksley, Satheesh Thomas, Sayyem H Akbar, Scott E Norris, Seema S Singh, Shari L Kahn, Shirley J Berryman, Simone E Pitts, Sina Shojaee, Sonia E Ortiz, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stacey S Degarmo, State Agency, Stella Yuen, Stephen D Brown, Steven J Libal, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Analyst, Susant Hadman, Syeda N Mahazabin, Taichun Qin, PhD, Tamil Arasu, PhD, Tammy Notto, Tammy S Notto, Tanya R Syffrard, Tara K Carmody, Tej Poonai, Tekalign Wondimu, Temar Q Williams, Teresa I Navas, Thomas J Arista, Thomas J Mooney, Thomas S Arista, Tina S Roecklein, Toyin B Oladimeji, Tracy K Li, Tyanna N Hadley, Uduak M Inokon, Unnee Ranjan, Valentino Fiorella, Valerie A Potopsingh, Valerie J Grecek Trinh, Vanessa M Williams, Vilmary Negron Rodriguez, Viviana R Ramirez, Vivin George, Vlada Matusovsky, Wayne E Seifert, Wayne T Smith, Winston R Alejo, Xiaokuang Lai, PhD, Xiaoping Guan, Yumi J Hiramine, Yvette Mlacour Davis, Yvins Dezan, Zada L Giles, Zhongren Wu

Demitria J Xiradakis's Documents

Publish Date Document Type Title
April, 2016 FDA 483 Town Total Compounding Center - Form 483, 2016-04-20
November, 2011 FDA 483 Ultra Seal Corporation - Form 483, 2011-11-15
August, 2013 FDA 483 SpecGx LLC - Form 483, 2013-08-30
November, 2011 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2011-11-15
September, 2002 FDA 483 Geritrex, LLC - Form 483, 2002-09-18
June, 2015 FDA 483 Hikma Pharmaceuticals LLC - Form 483, 2015-06-25
July, 2004 EIR Nepera, a Division of Rutherford Chemicals LLC - EIR, 2004-07-30
August, 2002 FDA 483 Silarx Pharmaceutical, Inc. - Form 483, 2002-08-08
March, 2008 FDA 483 Premier Brands of America Inc - Form 483, 2008-03-17
September, 2011 FDA 483 Acorda Therapeutics, Inc. - Form 483, 2011-09-09
April, 2006 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2006-04-13
January, 2004 EIR Breonics, Inc. - EIR, 2004-01-14
November, 2008 FDA 483 Watson Laboratories, Inc. - Form 483, 2008-11-26
September, 2003 EIR Avon Products Inc - EIR, 2003-09-26
April, 2002 EIR Lawrence Hospital - EIR, 2002-04-25
March, 2012 FDA 483 Response American Regent, Inc. - Form 483R, 2012-05-18
December, 2012 FDA 483 Lyophilization Services of New England, Inc. - Form 483, 2012-12-21
October, 2013 FDA 483 Auxilium Pharmaceuticals, LLC - Form 483, 2013-10-28
February, 2013 EIR Strides Pharma, Inc - EIR, 2013-02-19
May, 2008 FDA 483 Watson Laboratories, Inc. - Form 483, 2008-05-13
October, 2012 FDA 483 Pfizer Inc. - Form 483, 2012-10-15
July, 2005 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2005-07-25
July, 2002 EIR Auxilium Pharmaceuticals, LLC - EIR, 2002-07-01
October, 2009 FDA 483 SML Acquisition, LLC (aka San-mar Laboratories, Inc) - Form 483, 2009-10-20
July, 2004 FDA 483 Response Nepera, a Division of Rutherford Chemicals LLC - Form 483R, 2004-08-24
June, 2012 FDA 483 Teva API India Private Ltd. - Form 483, 2012-06-06
February, 2014 EIR Amneal Pharmaceuticals of New York, LLC - EIR, 2014-02-07
February, 2010 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2010-02-09
February, 2007 EIR Auxilium Pharmaceuticals, LLC - EIR, 2007-02-28
February, 2009 FDA 483 Ultra Seal Corporation - Form 483, 2009-02-11
May, 2008 FDA 483 Response Watson Laboratories, Inc. - Form 483R, 2008-06-10
June, 2015 EIR Epic Pharma, LLC - EIR, 2015-06-04
August, 2010 EIR Auxilium Pharmaceuticals, LLC - EIR, 2010-08-17
August, 2008 FDA 483 Professional Disposables International, Inc. - Form 483, 2008-08-12
May, 2010 FDA 483 Response ULTRAtab Laboratories, Inc. - Form 483R, 2010-06-15
November, 2009 EIR Auxilium Pharmaceuticals, LLC - EIR, 2009-11-24
August, 2009 FDA 483 Pfizer Inc. - Form 483, 2009-08-10
August, 2008 FDA 483 RIJ Pharmaceutical LLC - Form 483, 2008-08-04
March, 2004 FDA 483 Response Ultra Seal Corporation - Form 483R, 2004-04-06
November, 2008 FDA 483 Ivax Pharmaceuticals Inc A.k.a Teva Pharmaceuticals Usa - Form 483, 2008-11-03
March, 2014 FDA 483 Geritrex, LLC - Form 483, 2014-03-21
May, 2010 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2010-05-05
March, 2013 FDA 483 Chartwell Pharmaceuticals Carmel, LLC - Form 483, 2013-03-25
August, 2010 FDA 483 Ultra Seal Corporation - Form 483, 2010-08-03
July, 2003 EIR Barr Laboratories Inc. - EIR, 2003-07-29
October, 2006 FDA 483 Premier Brands of America Inc - Form 483, 2006-10-27
August, 2011 EIR Acorda Therapeutics, Inc. - EIR, 2011-08-11
December, 2011 FDA 483 Aptuit (Verona) Srl - Form 483, 2011-12-07
October, 2015 FDA 483 Geritrex, LLC - Form 483, 2015-10-19
March, 2004 FDA 483 Ultra Seal Corporation - Form 483, 2004-03-08
July, 2003 FDA 483 Barr Laboratories Inc. - Form 483, 2003-07-29
March, 2012 FDA 483 American Regent, Inc. - Form 483, 2012-03-29
April, 2014 FDA 483 Infusion Options, Inc. - Form 483, 2014-04-23
March, 2015 FDA 483 Advance Pharmaceutical, Inc. - Form 483, 2015-03-06
March, 2011 FDA 483 American Regent, Inc. - Form 483, 2011-03-15
August, 2013 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2013-08-02
April, 2002 FDA 483 Lawrence Hospital - Form 483, 2002-04-25
July, 2006 FDA 483 Ivax Pharmaceuticals Inc A.k.a Teva Pharmaceuticals Usa - Form 483, 2006-07-11
September, 2011 FDA 483 Response Acorda Therapeutics, Inc. - Form 483R, 2011-10-03
June, 2006 FDA 483 International Pharmaceuticals & Biotechnology Laboratories - Form 483, 2006-06-01
July, 2004 FDA 483 Nepera, a Division of Rutherford Chemicals LLC - Form 483, 2004-07-30
August, 2006 FDA 483 Perrigo New York, Inc. - Form 483, 2006-08-31
February, 2014 FDA 483 Amneal Pharmaceuticals of New York, LLC - Form 483, 2014-02-07
August, 2003 EIR Elementis SRL, Inc. - EIR, 2003-08-01
June, 2012 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2012-06-14
June, 2015 FDA 483 Epic Pharma, LLC - Form 483, 2015-06-04
March, 2008 FDA 483 Avon Products Inc - Form 483, 2008-03-03
July, 2016 FDA 483 Queens Express Pharmacy - Form 483, 2016-07-11
May, 2009 FDA 483 Taro Pharmaceuticals U.S.A., Inc. - Form 483, 2009-05-29
August, 2016 FDA 483 Alexander Infusion LLC D/B/A Avanti Health Care - Form 483, 2016-08-01

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more